<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"
                xmlns:wfw="http://wellformedweb.org/CommentAPI/"
                xmlns:dc="http://purl.org/dc/elements/1.1/"
                xmlns:sy="http://purl.org/rss/1.0/modules/syndication/">
<channel>
<title>Ambry Genetics News by Category: Clinical Research</title>
<link>https://blog.ambrygen.com/list/category/Clinical%20Research</link>
<description>Find the latest Ambry Genetics news by category: Clinical Research</description>
<language>en</language>
<image>
<title>Ambry Genetics Blog</title>
<link>https://blog.ambrygen.com/list/category/Clinical%20Research</link>
<url>https://blog.ambrygen.com/assets/img/logo/Ambry_logo_web.jpg</url>
</image>
<item>
<title>Study Finds One in Four People With Sarcoma Carry a Pathogenic Variant: Why Germline Testing Matters</title>
<link>https://blog.ambrygen.com/ambry/post/414/study-finds-one-in-four-people-with-sarcoma-carry-a-pathogenic-variant-why-germline-testing-matters</link>
<description>Huma Q Rana (Dana-Farber Cancer institute) explains a Journal of the National Cancer Institute study of whether germline pathogenic variants were more frequent in people with sarcoma than in cancer-free controls</description>
<pubDate>Tue, 30 Dec 25 06:52:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>SMARCA4 Pathogenic Variants: Gynecological Cancer Histories from a Laboratory Tested Cohort</title>
<link>https://blog.ambrygen.com/ambry/post/413/smarca4-pathogenic-variants-gynecological-cancer-histories-from-a-laboratory-tested-cohort</link>
<description>Dr. Adela Rodríguez-Hernández (Dana-Farber Cancer Institute) shares results from a study in Gynecologic Oncology that better characterized cancer patterns among individuals with SMARCA4 gPVs, addressing gaps in counseling, surveillance, and prevention.</description>
<pubDate>Wed, 17 Dec 25 06:28:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>From Research to Reclass: 4,200+ Patients Impacted...and Counting!</title>
<link>https://blog.ambrygen.com/ambry/post/387/from-research-to-reclass-4-200-patients-impacted-and-counting</link>
<description>The Ambry Classifi program proactively reclassifies BRCA2 variants as reported in the groundbreaking Nature study, Functional Evaluation and Clinical Classification of BRCA2 Variants.</description>
<pubDate>Tue, 26 Aug 25 06:39:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Pioneering New Research to Support Rare Disease Patients and Families</title>
<link>https://blog.ambrygen.com/ambry/post/358/pioneering-new-research-to-support-rare-disease-patients-and-families</link>
<description>Dr. Elizabeth Chao explains how Ambry's collaboration with PacBio to participate in the GREGoR Consortium to unlock the mysteries of the genome.</description>
<pubDate>Thu, 10 Oct 24 08:02:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>TCLR: Revisiting an Innovative Method for Mismatch Repair Variant Classification</title>
<link>https://blog.ambrygen.com/ambry/post/355/tclr-revisiting-an-innovative-method-for-mismatch-repair-variant-classification</link>
<description>Jessie Gryzbowski describes Ambry's novel method to accurately classify alterations in mismatch repair (MMR) genes​ ​by incorporating a tumor characteristic likelihood ratio (TCLR) into the variant assessment framework</description>
<pubDate>Wed, 03 Jul 24 06:57:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>The Evolving Landscape of Gene-Disease Validity Curation and Its Impact on Clinical Utility</title>
<link>https://blog.ambrygen.com/ambry/post/353/the-evolving-landscape-of-gene-disease-validity-curation-and-its-impact-on-clinical-utility</link>
<description>Understanding the relationship between genes and diseases is crucial for improving patient care. Gene-Disease Validity (GDV) scoring techniques continue to evolve</description>
<pubDate>Tue, 02 Jul 24 07:37:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>The Power of Progress: Philip's NF1 Clinical Trial Experience</title>
<link>https://blog.ambrygen.com/patient/post/351/the-power-of-progress-philips-nf1-clinical-trial-experience</link>
<description>Renie and Philip Moss share what it was like for Philip to participate in a clinical trial for NF1.</description>
<pubDate>Wed, 22 May 24 06:41:00 -0700</pubDate>
<source>Ambry Genetics Patient Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Navigating NF1: The Moss Family’s Story of Resilience and Hope</title>
<link>https://blog.ambrygen.com/patient/post/350/navigating-nf1-the-moss-familys-story-of-resilience-and-hope</link>
<description>Renie and Philip Moss shared experiences and insights from their NF1 journey for NF Awareness Month.</description>
<pubDate>Thu, 16 May 24 06:32:00 -0700</pubDate>
<source>Ambry Genetics Patient Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Meet Raymonde Saintil: Ambry Clinical Lab Manager</title>
<link>https://blog.ambrygen.com/ambry/post/333/meet-raymonde-saintil-ambry-clinical-lab-manager</link>
<description>Ambry highlights clinical lab manager Raymonde Saintil for International Day of Women and Girls in Science.</description>
<pubDate>Mon, 12 Feb 24 08:19:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Understanding Gene-Disease Validity in Breast Cancer: The Power of Evidence</title>
<link>https://blog.ambrygen.com/ambry/post/322/understanding-gene-disease-validity-in-breast-cancer-the-power-of-evidence</link>
<description>An overview of gene-disease validity in the context of breast cancer, which affects approximately 1 in every 8 women.</description>
<pubDate>Tue, 17 Oct 23 04:07:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Genetics in Medicine publication demonstrates a 10% lower rate of VUS with WES/WGS compared to panels</title>
<link>https://blog.ambrygen.com/ambry/post/319/genetics-in-medicine-publication-demonstrates-a-10-lower-rate-of-vus-with-wes-wgs-compared-to-panels</link>
<description>A discussion of VUS and explanation of their significance, highlighting Ambry's collaboration in the GIM publication, The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change.</description>
<pubDate>Wed, 20 Sep 23 04:18:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Genetic Counselors Make the Industry World Go Round</title>
<link>https://blog.ambrygen.com/ambry/post/292/genetic-counselors-make-the-industry-world-go-round</link>
<description>A day in the life of a genetic counselor is explored, along with all the roles a GC can fill in the industry.</description>
<pubDate>Tue, 08 Nov 22 06:00:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Direct-to-Consumer Genetic Testing: Taking the Trend to the Next Level…Responsibly</title>
<link>https://blog.ambrygen.com/ambry/post/185/direct-to-consumer-genetic-testing-taking-the-trend-to-the-next-level-responsibly</link>
<description>Direct-To-Consumer genetic testing is not intended to diagnose medical conditions, but rather provides carrier status and, at most, provides information about the probability of developing some diseases.</description>
<pubDate>Thu, 04 May 17 21:42:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Can Patients with Hematological Cancer Have Genetic Testing?</title>
<link>https://blog.ambrygen.com/ambry/post/171/can-patients-with-hematological-cancer-have-genetic-testing</link>
<description>Genetic testing for patients with hematological cancer can be tricky, but the tips found here simplify the process.</description>
<pubDate>Mon, 10 Apr 17 16:52:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Current Genetic Testing Guidelines Miss Some Families with CDH1 Mutations</title>
<link>https://blog.ambrygen.com/ambry/post/175/current-genetic-testing-guidelines-miss-some-families-with-cdh1-mutations</link>
<description>A new study aims to describe the clinical characteristics of CDH1 mutation carriers found through MGPT and offer informed recommendations for medical management.</description>
<pubDate>Mon, 03 Apr 17 12:06:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Four Reasons Why Genetic Testing Matters to the Individual with Colorectal Cancer</title>
<link>https://blog.ambrygen.com/ambry/post/164/four-reasons-why-genetic-testing-matters-to-the-individual-with-colorectal-cancer</link>
<description>Colorectal cancer is third most common cancer diagnosed in both American men and women. Here are four points for patients on how genetic testing can help.</description>
<pubDate>Tue, 14 Mar 17 23:45:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Scientific Research Consent Made Easy</title>
<link>https://blog.ambrygen.com/ambry/post/1/scientific-research-consent-made-easy</link>
<description>Now anyone can participate in a scientific research study through AmbryShare's simplified consent process.</description>
<pubDate>Thu, 16 Feb 17 17:25:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
<item>
<title>Ambry Supports 'Movember' with Clinical Research, Testing Menu Updates and...Mustaches</title>
<link>https://blog.ambrygen.com/ambry/post/12/ambry-supports-movember-with-clinical-research-testing-menu-updates-and-mustaches</link>
<description>The many male faces at Ambry are becoming a little scruffier in support of ‘Movember,’ an initiative dedicated to raising awareness about men’s health.</description>
<pubDate>Thu, 03 Nov 16 00:26:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Clinical Research</category>
</item>
</channel>
</rss>
